Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Head discomfort, Headache, Memory impairment, Nasopharyngitis
Clinical narrative: convulsive-like effects on my body; strong body aches; headaches; cold and shaking for around 30 minutes; cold and shaking for around 30 minutes; could not speak; blurry vision; I tend to forget a lot of things now; dizziness; My head there were sequels/It affects my head like never before; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 06Jan2022 14:15 (Batch/Lot number: unknown) at the age of 41 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown. Unable to locate or read the details, Location of injection: Arm Left, Vaccine Administration Time: 04:00 PM, administration date: 16Dec2021), administration date: 16Dec2021, when the patient was 41 years old, for COVID-19 Immunization, reaction(s): "body aches", "chills". The following information was reported: SEIZURE LIKE PHENOMENA (medically significant) with onset 07Jan2022 06:00, outcome "not recovered", described as "convulsive-like effects on my body"; PAIN (non-serious) with onset 07Jan2022 06:00, outcome "not recovered", described as "strong body aches"; HEADACHE (non-serious) with onset 07Jan2022 06:00, outcome "not recovered", described as "headaches"; NASOPHARYNGITIS (non-serious), TREMOR (non-serious) all with onset 07Jan2022 06:00, outcome "not recovered" and all described as "cold and shaking for around 30 minutes"; SPEECH DISORDER (non-serious) with onset 07Jan2022 06:00, outcome "not recovered", described as "could not speak"; VISION BLURRED (non-serious) with onset 07Jan2022 06:00, outcome "not recovered", described as "blurry vision"; MEMORY IMPAIRMENT (non-serious) with onset 07Jan2022 06:00, outcome "not recovered", described as "I tend to forget a lot of things now"; DIZZINESS (non-serious) with onset 07Jan2022 06:00, outcome "not recovered", described as "dizziness"; HEAD DISCOMFORT (non-serious) with onset 07Jan2022 06:00, outcome "not recovered", described as "My head there were sequels/It affects my head like never before". Therapeutic measures were not taken as a result of seizure like phenomena, pain, headache, nasopharyngitis, tremor, speech disorder, vision blurred, memory impairment, dizziness, head discomfort. Clinical course: Patient received her first covid-19 vaccine (Pfizer) from (Institute Name withheld) in (city withheld) on 16Dec2021 the next day she experienced body aches and chills. During the second vaccine on 06Jan2022 she experienced strong body aches, headaches and convulsive-like effects on her body, which was cold and shaking for around 30 minutes she could not speak and a severe headache for 30 minutes after that, she have blurry vision now. She tend to forget a lot of things now. Patients head there were sequels. She suffer from a lot of dizziness, headache, and blurred vision daily. It affects her head like never before she had experienced these symptoms. Patient did not receive any other vaccine within 4 weeks prior to COVID-19, patient received Myfembre within 2 weeks of vaccination. Patient was diagnosed with COVID-19 prior to vaccination and not tested for COVID-19 since the vaccination. The lot number for bnt162b2 was not provided and will be requested during follow up.